AVTR AVTR
Company Profile ↓Company Overview
AVTR (AVTR) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 23.0% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $6.55B (-3.4% YoY); net profit $-530.20M.
- Trailing 12 Months Year-on-year growth — revenue -3.4%, earnings -174.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 23.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 23.04% |
| 1 Year: | -3.41% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -174.52% |
Stock Price Performance
| 1 Year: | +18.23% |
| 6 Months: | +23.13% |
| 3 Months: | +65.96% |
| 1 Month: | +30.98% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross3d ago
- RSI (14)68.05 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 23.0% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.42B | 1.48B | 1.49B | 1.47B | 1.48B | 1.53B | 1.50B | 1.52B | 1.52B | 1.48B | 1.60B | 1.79B | 1.79B | 1.86B | 1.83B | 1.95B | 1.91B | 1.86B | 1.78B | 1.74B | 1.72B | 1.68B | 1.70B | 1.71B | - | - | 1.68B | 1.62B | 1.66B | 1.58B | 1.69B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.13B | 1.10B | 1.14B | 1.08B | 1.16B |
| Gross Profit | 440.30M | 468.00M | 478.70M | 432.80M | 475.20M | 491.10M | 474.00M | 480.40M | 501.90M | 490.60M | 506.40M | 581.60M | 612.80M | 626.50M | 615.90M | 689.90M | 647.70M | 650.70M | 624.80M | 590.00M | 578.60M | 570.50M | 581.50M | 564.40M | - | - | 554.10M | 526.50M | 523.90M | 500.70M | 537.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 425.30M | 390.30M | 392.40M | 401.20M | 415.20M |
| Operating Income | - | 94.40M | 132.20M | - | 137.60M | 119.10M | 143.20M | - | 158.40M | 166.60M | 177.20M | - | 266.30M | 254.70M | 237.20M | 307.00M | 295.60M | 275.80M | 231.20M | 71.70M | 210.20M | 146.30M | 175.80M | 124.60M | - | - | 128.80M | 136.20M | 131.50M | 99.50M | 121.80M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 227.80M | -540.80M | 224.10M | 203.40M | 226.20M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.40M | 44.20M | 40.00M | 42.90M | 39.40M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 81.70M | -689.50M | 80.80M | 55.50M | 81.20M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.00M | 22.30M | 28.40M | 12.20M | 43.10M |
| Net Income | - | -26.90M | 34.50M | - | -6.20M | -48.70M | 22.10M | 70.60M | 47.00M | 60.20M | -42.20M | 51.60M | 164.00M | 157.80M | 156.80M | 190.40M | 187.40M | 167.00M | 121.50M | -7.30M | 108.40M | 60.40M | 92.90M | 57.80M | - | - | 64.70M | -711.80M | 52.40M | 43.30M | 38.10M |
| Diluted EPS | -0.79 | -0.70 | -0.26 | -0.94 | -0.59 | -0.98 | 0.01 | 0.09 | 0.05 | 0.08 | -0.10 | 0.06 | 0.25 | 0.24 | 0.24 | 0.28 | 0.28 | 0.25 | 0.18 | -0.01 | 0.16 | 0.09 | 0.14 | 0.08 | - | - | 0.09 | -1.04 | 0.08 | 0.06 | 0.06 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.25B | 5.86B | 6.04B | 6.39B | 7.39B | 7.51B | 6.97B | 6.78B | 6.55B |
| Gross Profit | 432.80M | 1.82B | 1.92B | 2.08B | 2.50B | 2.60B | 2.36B | 2.28B | 2.14B |
| Operating Income | -210.40M | 413.50M | 551.80M | 706.80M | 972.20M | 1.13B | 696.40M | 1.08B | -246.20M |
| Net Income | -112.70M | -86.90M | 37.80M | 116.60M | 572.60M | 686.50M | 321.10M | 711.50M | -530.20M |
| Diluted EPS | - | -2.69 | -0.84 | 0.09 | 0.85 | 1.01 | 0.47 | 1.04 | -0.78 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 9.91B | 9.77B | 9.91B | 13.90B | 13.46B | 12.97B | 12.11B | 11.79B |
| Total Equity | -510.60M | -2.62B | -3.05B | 2.46B | 2.67B | 4.20B | 4.86B | 5.25B | 5.96B | 5.57B |
| Cash & Equivalents | - | - | 184.70M | 186.70M | 286.60M | 301.70M | 372.90M | 262.90M | 261.90M | 365.40M |
| Long Term Debt | - | - | 6.78B | 5.02B | 4.87B | 6.98B | 5.92B | 5.28B | 3.23B | 3.92B |
| Total Liabilities | - | - | 9.10B | 7.31B | 7.23B | 9.70B | 8.61B | 7.72B | 6.16B | 6.23B |
| Current Liabilities | - | - | 1.10B | 1.07B | 1.24B | 1.45B | 1.66B | 1.48B | 2.01B | 1.38B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -167.50M | 200.50M | 354.00M | 929.80M | 953.60M | 843.60M | 870.00M | 840.80M | 623.80M |
| Investing Cash Flow | -6.68B | -23.20M | -42.10M | -59.10M | -4.12B | -109.60M | -143.70M | 438.90M | -130.50M |
| Financing Cash Flow | 6.96B | -170.30M | -307.80M | -782.90M | 3.22B | -648.70M | -843.70M | -1.28B | -409.40M |
| Capital Expenditure | -25.20M | -37.70M | -51.60M | -61.60M | -111.10M | -133.40M | -146.40M | -148.80M | -128.80M |
| Free Cash Flow | -192.70M | 162.80M | 302.40M | 868.20M | 842.50M | 710.20M | 723.60M | 692.00M | 495.00M |
| Share Buybacks | - | - | - | - | - | - | 0 | 0 | 75.10M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 34.7% | 31.0% | 31.8% | 32.5% | 33.9% | 34.6% | 33.9% | 33.6% | 32.7% |
| Operating Margin % | -16.9% | 7.1% | 9.1% | 11.1% | 13.2% | 15.0% | 10.0% | 16.0% | -3.8% |
| Net Margin % | -9.0% | -1.5% | 0.6% | 1.8% | 7.8% | 9.1% | 4.6% | 10.5% | -8.1% |
| ROE % | 4.3% | 2.8% | 1.5% | 4.4% | 13.6% | 14.1% | 6.1% | 11.9% | -9.5% |
| ROCE % | - | 4.7% | 6.3% | 8.2% | 7.8% | 9.6% | 6.1% | 10.7% | -2.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AVTR
Are Medical Stocks Lagging Avantor (AVTR) This Year? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNbHI1ZkJQdkc3cUlhYndpWTZnM285aHUwVWh1R1JITlNRX25hUzdXdXBYRGVxVF9fZS10SEM4WC1LVlY5Ml96YXpPTWd2azdROXVKSzBVY28wWDk5cTVDbDZDekpRTm1nN2dxeXhXWUFsd3Vma1gyUkFjVFcwVkRnczlXVzBlYmVPVS1MOE…
Avantor Stock Price Forecast. Should You Buy AVTR? - StockInvest.us
<a href="https://news.google.com/rss/articles/CBMiSEFVX3lxTE1ZclR4UFp4RHpBcXVjOW94TFE0QXBXajR3R2VXYkJGbUpQenMwaThCRjY2TE5RZ2RhMFFMV1pHSDBObTd6LUdGVg?oc=5" target="_blank">Avantor Stock Price Forecast. Should You Buy AVTR?</a> <fo…
Avantor (NYSE: AVTR) CAO has 1,385 shares withheld for taxes - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQRkg4ZzM4QXRrdmxRQllZZFMxZFZKcW1tR3h3bVZKT0FOYlEtUTdnTUZJM0cxbnktd0d5YTQ1SmROOF9kalcwaG1kbDFycmFyaFlPN2ZSc0dOQWNWbnhZNk50X0xvR1NHY2p2SkF0dkZTRlVEMVphbVZkTjZlVTRKTjdXVGpGQU45Tk9YNE…
Avantor (AVTR) Stock Slips As Turnaround Progress Meets Profit Drop - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxNaExNeklFNUE4UnNKeWFuUC1oclFFRjFnZnc0ZWNlN1VjR1J5ZzRxbXVtWExpTWJoakFBY05ORHRlSktlazFnQnhTeldmNUYtcHhyOHFKQjJaTVlPMEJjQi1pWVJaeTIwSDNOV2liVmZ1cDBKSWhzWGVxZjM0N0lzTks1ZWtTeWJHVWJDQW…
Avantor Stock Surged Because One Segment Stopped Shrinking - Trefis
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPVDFFNTZUTDJGWVpsRnEtekNVZEdLbDhadGhldFhVLTlwYWs2R0U4VWpxYlNHczdGa0xMQjFFMmNDdURzWDRmYzlWejRLYXRqcGVfVUZsbmhsdjdTQ09TUTF3MUJ6UEdKa2tsTS1sVHFJUjMxUS1EclpEbUFhSEJkdExaUTFhQ0V3eXhBbz…
$AVTR stock is up 11% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNdXgwNk1tVEdGenlNd2NZNjB2MmdOSDJvYWZqNDRGNmFhNGdUTE5UWFdFSHQ4OXh2UEVGSnZ4VTF1cEg5Y0Q2VXRZZzVKczhsUGNVd0ZKX0RFTmQ1c29QQk5ub0VoNEFkS29nNFBWYVN4blE4TG85QmFKQmVpWWJjbURnMFlGVTF1ZVFfZU…
AVTR — Frequently Asked Questions
What is the current share price of AVTR?
As of 2026-08-05 17:25 PDT, AVTR trades at $13.36 on NASDAQ/NYSE. Its 52-week range is $7.41 to $15.60.
What is the P/E ratio of AVTR?
AVTR trades at a trailing price-to-earnings (P/E) ratio of -17.13.
What is the return on equity (ROE) of AVTR?
AVTR has a return on equity (ROE) of -9.53%. Its return on capital employed (ROCE) is -2.36%.
Is AVTR a good stock to buy?
This page provides a data-driven analysis of AVTR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.